<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-10-01" modified="2020-10-07" version="203">
<accession>P32121</accession>
<accession>B4DLW0</accession>
<accession>B5B0C0</accession>
<accession>B7WPL3</accession>
<accession>D3DTK2</accession>
<accession>H0Y688</accession>
<accession>Q0Z8D3</accession>
<accession>Q2PP19</accession>
<accession>Q6ICT3</accession>
<accession>Q8N7Y2</accession>
<accession>Q9UEQ6</accession>
<name>ARRB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Beta-arrestin-2</fullName>
</recommendedName>
<alternativeName>
<fullName>Arrestin beta-2</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="48">Non-visual arrestin-3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ARRB2</name>
<name type="synonym">ARB2</name>
<name type="synonym">ARR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Mol. Cell. Endocrinol." volume="84" first="R39" last="R43">
<title>Cloning of a member of the arrestin family from a human thyroid cDNA library.</title>
<authorList>
<person name="Rapoport B."/>
<person name="Kaufman K.D."/>
<person name="Chamenbalk G.D."/>
</authorList>
<dbReference type="PubMed" id="1587386"/>
<dbReference type="DOI" id="10.1016/0303-7207(92)90038-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Thyroid</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-11" db="EMBL/GenBank/DDBJ databases">
<title>G-protein coupled receptor interaction with beta-arrestin 2 through specific agonist stimulation.</title>
<authorList>
<person name="Yu Q.M."/>
<person name="Zhou T.H."/>
<person name="Wu Y.L."/>
<person name="Cheng Z.J."/>
<person name="Ma L."/>
<person name="Pei G."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2006-05" db="EMBL/GenBank/DDBJ databases">
<title>A new splice-variant of beta-arrestin 2 is involved in agonist-induced MC1R endocytosis.</title>
<authorList>
<person name="Sanchez-Laorden B.L."/>
<person name="Jimenez-Cervantes C."/>
<person name="Garcia-Borron J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2008-07" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of cDNA coding for human arrestin, beta 2 (ARRB2), transcript variant 1.</title>
<authorList>
<person name="Kaighin V.A."/>
<person name="Martin A.L."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27497" last="27500">
<title>A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.</title>
<authorList>
<person name="Barak L.S."/>
<person name="Ferguson S.S.G."/>
<person name="Zhang J."/>
<person name="Caron M.G."/>
</authorList>
<dbReference type="PubMed" id="9346876"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27497"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH GPCRS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="2479" last="2485">
<title>beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4.</title>
<authorList>
<person name="Cheng Z.J."/>
<person name="Zhao J."/>
<person name="Sun Y."/>
<person name="Hu W."/>
<person name="Wu Y.L."/>
<person name="Cen B."/>
<person name="Wu G.-X."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="10644702"/>
<dbReference type="DOI" id="10.1074/jbc.275.4.2479"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF CXCR4</scope>
<scope>INTERACTION WITH CXCR4</scope>
<scope>MUTAGENESIS OF VAL-54</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="17201" last="17210">
<title>Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.</title>
<authorList>
<person name="Oakley R.H."/>
<person name="Laporte S.A."/>
<person name="Holt J.A."/>
<person name="Caron M.G."/>
<person name="Barak L.S."/>
</authorList>
<dbReference type="PubMed" id="10748214"/>
<dbReference type="DOI" id="10.1074/jbc.m910348199"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH ANTAGONIST-STIMULATED GPCRS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Nat. Immunol." volume="1" first="227" last="233">
<title>Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.</title>
<authorList>
<person name="Barlic J."/>
<person name="Andrews J.D."/>
<person name="Kelvin A.A."/>
<person name="Bosinger S.E."/>
<person name="DeVries M.E."/>
<person name="Xu L."/>
<person name="Dobransky T."/>
<person name="Feldman R.D."/>
<person name="Ferguson S.S."/>
<person name="Kelvin D.J."/>
</authorList>
<dbReference type="PubMed" id="10973280"/>
<dbReference type="DOI" id="10.1038/79767"/>
</citation>
<scope>INTERACTION WITH HCK AND CXCR1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="19452" last="19460">
<title>Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.</title>
<authorList>
<person name="Oakley R.H."/>
<person name="Laporte S.A."/>
<person name="Holt J.A."/>
<person name="Barak L.S."/>
<person name="Caron M.G."/>
</authorList>
<dbReference type="PubMed" id="11279203"/>
<dbReference type="DOI" id="10.1074/jbc.m101450200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH ANTAGONIST-STIMULATED GPCRS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16837" last="16846">
<title>Regulation of arrestin-3 phosphorylation by casein kinase II.</title>
<authorList>
<person name="Kim Y.-M."/>
<person name="Barak L.S."/>
<person name="Caron M.G."/>
<person name="Benovic J.L."/>
</authorList>
<dbReference type="PubMed" id="11877451"/>
<dbReference type="DOI" id="10.1074/jbc.m201379200"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF ADBR2</scope>
<scope>PHOSPHORYLATION AT THR-382</scope>
<scope>INTERACTION WITH AP2B1; CLATHRIN AND SRC</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-382</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6363" last="6370">
<title>Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2.</title>
<authorList>
<person name="Wang P."/>
<person name="Gao H."/>
<person name="Ni Y."/>
<person name="Wang B."/>
<person name="Wu Y."/>
<person name="Ji L."/>
<person name="Qin L."/>
<person name="Ma L."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="12488444"/>
<dbReference type="DOI" id="10.1074/jbc.m210350200"/>
</citation>
<scope>FUNCTION IN TP53-MEDIATED APOPTOSIS</scope>
<scope>INTERACTION WITH MDM2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="1740" last="1744">
<title>Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference.</title>
<authorList>
<person name="Ahn S."/>
<person name="Nelson C.D."/>
<person name="Garrison T.R."/>
<person name="Miller W.E."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="12582207"/>
<dbReference type="DOI" id="10.1073/pnas.262789099"/>
</citation>
<scope>FUNCTION IN DESENSITIZATION OF ADRB2</scope>
<scope>FUNCTION IN INTERNALIZATION OF ADRB2</scope>
<scope>FUNCTION IN INTERNALIZATION OF AGTR1</scope>
<scope>FUNCTION IN AGTR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="10782" last="10787">
<title>Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.</title>
<authorList>
<person name="Wei H."/>
<person name="Ahn S."/>
<person name="Shenoy S.K."/>
<person name="Karnik S.S."/>
<person name="Hunyady L."/>
<person name="Luttrell L.M."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="12949261"/>
<dbReference type="DOI" id="10.1073/pnas.1834556100"/>
</citation>
<scope>FUNCTION IN AGTR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Science" volume="301" first="1394" last="1397">
<title>Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling.</title>
<authorList>
<person name="Chen W."/>
<person name="Kirkbride K.C."/>
<person name="How T."/>
<person name="Nelson C.D."/>
<person name="Mo J."/>
<person name="Frederick J.P."/>
<person name="Wang X.-F."/>
<person name="Lefkowitz R.J."/>
<person name="Blobe G.C."/>
</authorList>
<dbReference type="PubMed" id="12958365"/>
<dbReference type="DOI" id="10.1126/science.1083195"/>
</citation>
<scope>FUNCTION IN ENDOCYTOSIS OF TGFBR2 AND TGFBR3</scope>
<scope>FUNCTION IN TGF-BETA SIGNALING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7807" last="7811">
<title>Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.</title>
<authorList>
<person name="Ahn S."/>
<person name="Wei H."/>
<person name="Garrison T.R."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="14711824"/>
<dbReference type="DOI" id="10.1074/jbc.c300443200"/>
</citation>
<scope>FUNCTION IN AGTR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="23214" last="23222">
<title>Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.</title>
<authorList>
<person name="Kohout T.A."/>
<person name="Nicholas S.L."/>
<person name="Perry S.J."/>
<person name="Reinhart G."/>
<person name="Junger S."/>
<person name="Struthers R.S."/>
</authorList>
<dbReference type="PubMed" id="15054093"/>
<dbReference type="DOI" id="10.1074/jbc.m402125200"/>
</citation>
<scope>FUNCTION IN CCR7-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="35518" last="35525">
<title>Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.</title>
<authorList>
<person name="Ahn S."/>
<person name="Shenoy S.K."/>
<person name="Wei H."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15205453"/>
<dbReference type="DOI" id="10.1074/jbc.m405878200"/>
</citation>
<scope>FUNCTION IN AGTR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="303" last="317">
<title>Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways.</title>
<authorList>
<person name="Gao H."/>
<person name="Sun Y."/>
<person name="Wu Y."/>
<person name="Luan B."/>
<person name="Wang Y."/>
<person name="Qu B."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="15125834"/>
<dbReference type="DOI" id="10.1016/s1097-2765(04)00216-3"/>
</citation>
<scope>FUNCTION IN REGULATION OF NF-KAPPA-B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CHUK AND RELA</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Science" volume="306" first="2257" last="2260">
<title>Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2.</title>
<authorList>
<person name="Chen W."/>
<person name="Ren X.R."/>
<person name="Nelson C.D."/>
<person name="Barak L.S."/>
<person name="Chen J.K."/>
<person name="Beachy P.A."/>
<person name="de Sauvage F."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15618519"/>
<dbReference type="DOI" id="10.1126/science.1104135"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF SMO</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24412" last="24419">
<title>{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.</title>
<authorList>
<person name="Girnita L."/>
<person name="Shenoy S.K."/>
<person name="Sehat B."/>
<person name="Vasilcanu R."/>
<person name="Girnita A."/>
<person name="Lefkowitz R.J."/>
<person name="Larsson O."/>
</authorList>
<dbReference type="PubMed" id="15878855"/>
<dbReference type="DOI" id="10.1074/jbc.m501129200"/>
</citation>
<scope>FUNCTION IN UBIQUITINATION OF IGF1R</scope>
<scope>INTERACTION WITH IGF1R AND MDM2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="25651" last="25658">
<title>Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.</title>
<authorList>
<person name="Willoughby E.A."/>
<person name="Collins M.K."/>
</authorList>
<dbReference type="PubMed" id="15888437"/>
<dbReference type="DOI" id="10.1074/jbc.m501926200"/>
</citation>
<scope>INTERACTION WITH DUSP16</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37503" last="37515">
<title>G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.</title>
<authorList>
<person name="Huettenrauch F."/>
<person name="Pollok-Kopp B."/>
<person name="Oppermann M."/>
</authorList>
<dbReference type="PubMed" id="16144840"/>
<dbReference type="DOI" id="10.1074/jbc.m500535200"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF CCR5</scope>
<scope>INTERACTION WITH CCR5</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Mol. Pharmacol." volume="67" first="78" last="87">
<title>Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.</title>
<authorList>
<person name="Stalheim L."/>
<person name="Ding Y."/>
<person name="Gullapalli A."/>
<person name="Paing M.M."/>
<person name="Wolfe B.L."/>
<person name="Morris D.R."/>
<person name="Trejo J."/>
</authorList>
<dbReference type="PubMed" id="15475570"/>
<dbReference type="DOI" id="10.1124/mol.104.006072"/>
</citation>
<scope>FUNCTION IN F2LR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Mol. Pharmacol." volume="67" first="1229" last="1236">
<title>Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.</title>
<authorList>
<person name="Hunton D.L."/>
<person name="Barnes W.G."/>
<person name="Kim J."/>
<person name="Ren X.-R."/>
<person name="Violin J.D."/>
<person name="Reiter E."/>
<person name="Milligan G."/>
<person name="Patel D.D."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15635042"/>
<dbReference type="DOI" id="10.1124/mol.104.006270"/>
</citation>
<scope>FUNCTION IN AGTR1-MEDIATED CHEMOTAXIS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1448" last="1453">
<title>Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.</title>
<authorList>
<person name="Ren X.-R."/>
<person name="Reiter E."/>
<person name="Ahn S."/>
<person name="Kim J."/>
<person name="Chen W."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15671180"/>
<dbReference type="DOI" id="10.1073/pnas.0409534102"/>
</citation>
<scope>FUNCTION IN AVPR2-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="2790" last="2795">
<title>beta-Arrestins bind and decrease cell-surface abundance of the Na+/H+ exchanger NHE5 isoform.</title>
<authorList>
<person name="Szabo E.Z."/>
<person name="Numata M."/>
<person name="Lukashova V."/>
<person name="Iannuzzi P."/>
<person name="Orlowski J."/>
</authorList>
<dbReference type="PubMed" id="15699339"/>
<dbReference type="DOI" id="10.1073/pnas.0407444102"/>
</citation>
<scope>FUNCTION IN ENDOCYTOSIS OF SLC9A5</scope>
<scope>INTERACTION WITH SLC9A5</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Dev. Cell" volume="10" first="329" last="342">
<title>Molecular switches involving the AP-2 beta2 appendage regulate endocytic cargo selection and clathrin coat assembly.</title>
<authorList>
<person name="Edeling M.A."/>
<person name="Mishra S.K."/>
<person name="Keyel P.A."/>
<person name="Steinhauser A.L."/>
<person name="Collins B.M."/>
<person name="Roth R."/>
<person name="Heuser J.E."/>
<person name="Owen D.J."/>
<person name="Traub L.M."/>
</authorList>
<dbReference type="PubMed" id="16516836"/>
<dbReference type="DOI" id="10.1016/j.devcel.2006.01.016"/>
</citation>
<scope>INTERACTION WITH AP2B1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="1261" last="1273">
<title>beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.</title>
<authorList>
<person name="Shenoy S.K."/>
<person name="Drake M.T."/>
<person name="Nelson C.D."/>
<person name="Houtz D.A."/>
<person name="Xiao K."/>
<person name="Madabushi S."/>
<person name="Reiter E."/>
<person name="Premont R.T."/>
<person name="Lichtarge O."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="16280323"/>
<dbReference type="DOI" id="10.1074/jbc.m506576200"/>
</citation>
<scope>FUNCTION IN ADRB2-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="2932" last="2938">
<title>A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors.</title>
<authorList>
<person name="Marion S."/>
<person name="Oakley R.H."/>
<person name="Kim K.-M."/>
<person name="Caron M.G."/>
<person name="Barak L.S."/>
</authorList>
<dbReference type="PubMed" id="16319069"/>
<dbReference type="DOI" id="10.1074/jbc.m508074200"/>
</citation>
<scope>INTERACTION WITH HTR2C</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="10856" last="10864">
<title>Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.</title>
<authorList>
<person name="Gesty-Palmer D."/>
<person name="Chen M."/>
<person name="Reiter E."/>
<person name="Ahn S."/>
<person name="Nelson C.D."/>
<person name="Wang S."/>
<person name="Eckhardt A.E."/>
<person name="Cowan C.L."/>
<person name="Spurney R.F."/>
<person name="Luttrell L.M."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="16492667"/>
<dbReference type="DOI" id="10.1074/jbc.m513380200"/>
</citation>
<scope>FUNCTION IN PTH1R-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="3047" last="3056">
<title>Novel function of beta-arrestin2 in the nucleus of mature spermatozoa.</title>
<authorList>
<person name="Neuhaus E.M."/>
<person name="Mashukova A."/>
<person name="Barbour J."/>
<person name="Wolters D."/>
<person name="Hatt H."/>
</authorList>
<dbReference type="PubMed" id="16820410"/>
<dbReference type="DOI" id="10.1242/jcs.03046"/>
</citation>
<scope>FUNCTION IN THE NUCLEUS OF SPERMATOZOA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DHX8; GAPDHS; H2AFX; KIF14 AND RCC1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="139" last="147">
<title>Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling.</title>
<authorList>
<person name="Wang Y."/>
<person name="Tang Y."/>
<person name="Teng L."/>
<person name="Wu Y."/>
<person name="Zhao X."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="16378096"/>
<dbReference type="DOI" id="10.1038/ni1294"/>
</citation>
<scope>FUNCTION IN TLR/IL-1 RECEPTOR SIGNALING</scope>
<scope>INTERACTION WITH TRAF6</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="Pigment Cell Res." volume="19" first="125" last="135">
<title>The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor.</title>
<authorList>
<person name="Innamorati G."/>
<person name="Piccirillo R."/>
<person name="Bagnato P."/>
<person name="Palmisano I."/>
<person name="Schiaffino M.V."/>
</authorList>
<dbReference type="PubMed" id="16524428"/>
<dbReference type="DOI" id="10.1111/j.1600-0749.2006.00292.x"/>
</citation>
<scope>INTERACTION WITH GPR143</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="21507" last="21517">
<title>The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells.</title>
<authorList>
<person name="Lee N.Y."/>
<person name="Blobe G.C."/>
</authorList>
<dbReference type="PubMed" id="17540773"/>
<dbReference type="DOI" id="10.1074/jbc.m700176200"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF ENG</scope>
<scope>FUNCTION IN TGF-BETA-MEDIATED ERK SIGNALING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ENG</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="J. Neurochem." volume="106" first="781" last="792">
<title>Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.</title>
<authorList>
<person name="Zhang X."/>
<person name="Wang F."/>
<person name="Chen X."/>
<person name="Chen Y."/>
<person name="Ma L."/>
</authorList>
<dbReference type="PubMed" id="18419762"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2008.05431.x"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF OPRD1</scope>
<scope>FUNCTION IN DEGRADATION OF OPRD1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Nat. Immunol." volume="9" first="898" last="907">
<title>An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells.</title>
<authorList>
<person name="Yu M.-C."/>
<person name="Su L.-L."/>
<person name="Zou L."/>
<person name="Liu Y."/>
<person name="Wu N."/>
<person name="Kong L."/>
<person name="Zhuang Z.-H."/>
<person name="Sun L."/>
<person name="Liu H.P."/>
<person name="Hu J.-H."/>
<person name="Li D."/>
<person name="Strominger J.L."/>
<person name="Zang J.-W."/>
<person name="Pei G."/>
<person name="Ge B.-X."/>
</authorList>
<dbReference type="PubMed" id="18604210"/>
<dbReference type="DOI" id="10.1038/ni.1635"/>
</citation>
<scope>FUNCTION IN REGULATION OF INNATE IMMUNE RESPONSE</scope>
<scope>INTERACTION WITH KIR2DL1; KIR2DL3 AND KIR2DL4</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Carcinogenesis" volume="30" first="1281" last="1287">
<title>The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.</title>
<authorList>
<person name="You H.J."/>
<person name="How T."/>
<person name="Blobe G.C."/>
</authorList>
<dbReference type="PubMed" id="19325136"/>
<dbReference type="DOI" id="10.1093/carcin/bgp071"/>
</citation>
<scope>FUNCTION IN TGFBR3-MEDIATED NF-KAPPA-B REGULATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1748" last="1757">
<title>Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2.</title>
<authorList>
<person name="Garcia Lopez M.A."/>
<person name="Aguado Martinez A."/>
<person name="Lamaze C."/>
<person name="Martinez-Alonso C."/>
<person name="Fischer T."/>
</authorList>
<dbReference type="PubMed" id="19643177"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.07.010"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF CCR2</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="FEBS Lett." volume="583" first="3310" last="3316">
<title>A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.</title>
<authorList>
<person name="Li X."/>
<person name="MacLeod R."/>
<person name="Dunlop A.J."/>
<person name="Edwards H.V."/>
<person name="Advant N."/>
<person name="Gibson L.C."/>
<person name="Devine N.M."/>
<person name="Brown K.M."/>
<person name="Adams D.R."/>
<person name="Houslay M.D."/>
<person name="Baillie G.S."/>
</authorList>
<dbReference type="PubMed" id="19782076"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.09.035"/>
</citation>
<scope>INTERACTION WITH MAP2K4/MKK4</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="J. Leukoc. Biol." volume="86" first="833" last="845">
<title>An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages.</title>
<authorList>
<person name="Cheung R."/>
<person name="Malik M."/>
<person name="Ravyn V."/>
<person name="Tomkowicz B."/>
<person name="Ptasznik A."/>
<person name="Collman R.G."/>
</authorList>
<dbReference type="PubMed" id="19620252"/>
<dbReference type="DOI" id="10.1189/jlb.0908551"/>
</citation>
<scope>FUNCTION IN MIP-1-BETA-STIMULATED CHEMOTAXIS</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="6650" last="6655">
<title>Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.</title>
<authorList>
<person name="Shenoy S.K."/>
<person name="Modi A.S."/>
<person name="Shukla A.K."/>
<person name="Xiao K."/>
<person name="Berthouze M."/>
<person name="Ahn S."/>
<person name="Wilkinson K.D."/>
<person name="Miller W.E."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="19363159"/>
<dbReference type="DOI" id="10.1073/pnas.0901083106"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP33</scope>
<scope>INTERACTION WITH USP33</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="7805" last="7817">
<title>Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling.</title>
<authorList>
<person name="Busillo J.M."/>
<person name="Armando S."/>
<person name="Sengupta R."/>
<person name="Meucci O."/>
<person name="Bouvier M."/>
<person name="Benovic J.L."/>
</authorList>
<dbReference type="PubMed" id="20048153"/>
<dbReference type="DOI" id="10.1074/jbc.m109.091173"/>
</citation>
<scope>INTERACTION WITH CXCR4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="J. Cell. Mol. Med." volume="15" first="2712" last="2722">
<title>Prolyl hydroxylase 2: a novel regulator of beta2 -adrenoceptor internalization.</title>
<authorList>
<person name="Yan B."/>
<person name="Huo Z."/>
<person name="Liu Y."/>
<person name="Lin X."/>
<person name="Li J."/>
<person name="Peng L."/>
<person name="Zhao H."/>
<person name="Zhou Z.N."/>
<person name="Liang X."/>
<person name="Liu Y."/>
<person name="Zhu W."/>
<person name="Liang D."/>
<person name="Li L."/>
<person name="Sun Y."/>
<person name="Cui J."/>
<person name="Chen Y.H."/>
</authorList>
<dbReference type="PubMed" id="21255264"/>
<dbReference type="DOI" id="10.1111/j.1582-4934.2011.01268.x"/>
</citation>
<scope>HYDROXYLATION AT PRO-176 AND PRO-181</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2012" name="Int. J. Biochem. Cell Biol." volume="44" first="669" last="678">
<title>Carboxy-terminus of CXCR7 regulates receptor localization and function.</title>
<authorList>
<person name="Ray P."/>
<person name="Mihalko L.A."/>
<person name="Coggins N.L."/>
<person name="Moudgil P."/>
<person name="Ehrlich A."/>
<person name="Luker K.E."/>
<person name="Luker G.D."/>
</authorList>
<dbReference type="PubMed" id="22300987"/>
<dbReference type="DOI" id="10.1016/j.biocel.2012.01.007"/>
</citation>
<scope>INTERACTION WITH ACKR3</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2012" name="Mol. Pharmacol." volume="81" first="631" last="642">
<title>Differential signaling by splice variants of the human free fatty acid receptor GPR120.</title>
<authorList>
<person name="Watson S.J."/>
<person name="Brown A.J."/>
<person name="Holliday N.D."/>
</authorList>
<dbReference type="PubMed" id="22282525"/>
<dbReference type="DOI" id="10.1124/mol.111.077388"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FFAR4</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E34192" last="E34192">
<title>Ubiquitination of CXCR7 controls receptor trafficking.</title>
<authorList>
<person name="Canals M."/>
<person name="Scholten D.J."/>
<person name="de Munnik S."/>
<person name="Han M.K."/>
<person name="Smit M.J."/>
<person name="Leurs R."/>
</authorList>
<dbReference type="PubMed" id="22457824"/>
<dbReference type="DOI" id="10.1371/journal.pone.0034192"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACKR3</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="Immunity" volume="38" first="1154" last="1163">
<title>Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.</title>
<authorList>
<person name="Yan Y."/>
<person name="Jiang W."/>
<person name="Spinetti T."/>
<person name="Tardivel A."/>
<person name="Castillo R."/>
<person name="Bourquin C."/>
<person name="Guarda G."/>
<person name="Tian Z."/>
<person name="Tschopp J."/>
<person name="Zhou R."/>
</authorList>
<dbReference type="PubMed" id="23809162"/>
<dbReference type="DOI" id="10.1016/j.immuni.2013.05.015"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NLRP3</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="7169" last="7181">
<title>Beta-arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.</title>
<authorList>
<person name="Watts A.O."/>
<person name="Verkaar F."/>
<person name="van der Lee M.M."/>
<person name="Timmerman C.A."/>
<person name="Kuijer M."/>
<person name="van Offenbeek J."/>
<person name="van Lith L.H."/>
<person name="Smit M.J."/>
<person name="Leurs R."/>
<person name="Zaman G.J."/>
<person name="Vischer H.F."/>
</authorList>
<dbReference type="PubMed" id="23341447"/>
<dbReference type="DOI" id="10.1074/jbc.m112.406108"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ACKR4</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="4457" last="4468">
<title>Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals.</title>
<authorList>
<person name="Puca L."/>
<person name="Chastagner P."/>
<person name="Meas-Yedid V."/>
<person name="Israel A."/>
<person name="Brou C."/>
</authorList>
<dbReference type="PubMed" id="23886940"/>
<dbReference type="DOI" id="10.1242/jcs.130500"/>
</citation>
<scope>INTERACTION WITH ARRDC1</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="8990" last="8990">
<title>Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions.</title>
<authorList>
<person name="Oishi A."/>
<person name="Karamitri A."/>
<person name="Gerbier R."/>
<person name="Lahuna O."/>
<person name="Ahmad R."/>
<person name="Jockers R."/>
</authorList>
<dbReference type="PubMed" id="28827538"/>
<dbReference type="DOI" id="10.1038/s41598-017-08996-7"/>
</citation>
<scope>INTERACTION WITH GPR61; GPR62 AND GPR135</scope>
</reference>
<comment type="function">
<text evidence="4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 22 23 25 26 29 30 31 32 33 35 36 38 40 42 44">Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN. Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of proinflammatory cytokine release and inhibition of inflammation (PubMed:23809162).</text>
</comment>
<comment type="subunit">
<text evidence="1 4 5 6 7 13 19 20 21 22 24 25 27 28 29 30 32 34 37 38 40 41 42 43 44 45 46 50">Homooligomer; the self-association is mediated by InsP6-binding (Probable). Heterooligomer with ARRB1; the association is mediated by InsP6-binding. Interacts with ADRB2 AND CHRM2. Interacts with PDE4A. Interacts with PDE4D. Interacts with MAPK10, MAPK1 and MAPK3. Interacts with DRD2. Interacts with FSHR. Interacts with CLTC. Interacts with HTR2C. Interacts with CCR5. Interacts with CXCR4. Interacts with SRC. Interacts with DUSP16; the interaction is interrupted by stimulation of AGTR1 and activation of MAPK10. Interacts with CHUK; the interaction is enhanced stimulation of ADRB2. Interacts with RELA. Interacts with MDM2; the interaction is enhanced by activation of GPCRs. Interacts with SLC9A5. Interacts with TRAF6. Interacts with IGF1R. Interacts with ENG. Interacts with KIR2DL1, KIR2DL3 and KIR2DL4. Interacts with LDLR. Interacts with AP2B1. Interacts with C5AR1. Interacts with RAF1. Interacts with MAP2K1. Interacts with MAPK1. Interacts with MAPK10; the interaction enhances MAPK10 activation by MAP3K5. Interacts with MAP2K4; the interaction is enhanced by presence of MAP3K5 and MAPK10. Interacts with MAP3K5. Interacts with AKT1. Interacts with IKBKB and MAP3K14. Interacts with SMO (activated). Interacts with GSK3A and GSK3B. Associates with protein phosphatase 2A (PP2A) (By similarity). Interacts with DHX8; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with GAPDHS; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with H2AFX; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with KIF14; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with RCC1; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with CXCR4; the interaction is dependent on C-terminal phosphorylation of CXCR4 and allows activation of MAPK1 and MAPK3. Interacts with GPR143. Interacts with HCK and CXCR1 (phosphorylated). Interacts with ACKR3 and ACKR4. Interacts with ARRDC1; the interaction is direct (PubMed:23886940). Interacts with GPR61, GPR62 and GPR135 (PubMed:28827538). Interacts (via NACHT and LRR domains) with NLRP3; this interaction is direct and inducible by omega-3 polyunsaturated fatty acids (PUFAs) (PubMed:23809162). Interacts with FFAR4 (via C-terminus); this interaction is stimulated by long-chain fatty acids (LCFAs) (PubMed:22282525).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-491169">
<id>P07550</id>
<label>ADRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-397435">
<id>P0DP25</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-351886">
<id>Q14247</id>
<label>CTTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-6624559">
<id>P25101</id>
<label>EDNRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-351506">
<id>P06396</id>
<label>GSN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-15558981">
<id>P06213-1</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-49776">
<id>Q13233</id>
<label>MAP3K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-476263">
<id>Q99683</id>
<label>MAP3K5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-959949">
<id>P28482</id>
<label>MAPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-713568">
<id>P45984</id>
<label>MAPK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-346967">
<id>P19338</id>
<label>NCL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-396155">
<id>Q14978</id>
<label>NOLC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-1642831">
<id>Q08499</id>
<label>PDE4D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-8095525">
<id>Q08499-2</id>
<label>PDE4D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-353408">
<id>P14618</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-989143">
<id>P35813</id>
<label>PPM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-1047039">
<id>O75688</id>
<label>PPM1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-395940">
<id>Q13523</id>
<label>PRPF4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-1055001">
<id>P06702</id>
<label>S100A9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-458376">
<id>Q15208</id>
<label>STK38</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-358643">
<id>Q15750</id>
<label>TAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-396105">
<id>Q13428</id>
<label>TCOF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-1051583">
<id>O95218</id>
<label>ZRANB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-298707">
<id>P31750</id>
<label>Akt1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-6248094">
<id>Q9Q2G4</id>
<label>ORF</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714559">
<id>P32121</id>
</interactant>
<interactant intactId="EBI-867790">
<id>P40417</id>
<label>rl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Membrane</location>
<location evidence="1">Clathrin-coated pit</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<text>Translocates to the plasma membrane and colocalizes with antagonist-stimulated GPCRs.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P32121-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P32121-3</id>
<name>2</name>
<sequence type="described" ref="VSP_008195"/>
</isoform>
<isoform>
<id>P32121-2</id>
<name>3</name>
<sequence type="described" ref="VSP_008194 VSP_008195"/>
</isoform>
<isoform>
<id>P32121-4</id>
<name>4</name>
<sequence type="described" ref="VSP_044697"/>
</isoform>
<isoform>
<id>P32121-5</id>
<name>5</name>
<sequence type="described" ref="VSP_008194"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="1">The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1.</text>
</comment>
<comment type="PTM">
<text evidence="6">Phosphorylated at Thr-382 in the cytoplasm; probably dephosphorylated at the plasma membrane. The phosphorylation does not regulate internalization and recycling of ADRB2, interaction with clathrin or AP2B1.</text>
</comment>
<comment type="PTM">
<text evidence="34">The ubiquitination status appears to regulate the formation and trafficking of beta-arrestin-GPCR complexes and signaling. Ubiquitination appears to occur GPCR-specific. Ubiquitinated by MDM2; the ubiquitination is required for rapid internalization of ADRB2. Deubiquitinated by USP33; the deubiquitination leads to a dissociation of the beta-arrestin-GPCR complex. Stimulation of a class A GPCR, such as ADRB2, induces transient ubiquitination and subsequently promotes association with USP33. Stimulation of a class B GPCR promotes a sustained ubiquitination.</text>
</comment>
<comment type="PTM">
<text evidence="39">Hydroxylation by PHD2 modulates the rate of internalization by slowing down recruitment to the plasma membrane and inhibiting subsequent co-internalization with class A receptors.</text>
</comment>
<comment type="similarity">
<text evidence="50">Belongs to the arrestin family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Arrestin"/>
<text>Arrestin entry</text>
</comment>
<dbReference type="EMBL" id="Z11501">
<property type="protein sequence ID" value="CAA77577.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF106941">
<property type="protein sequence ID" value="AAC99468.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ664180">
<property type="protein sequence ID" value="ABG47460.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU883572">
<property type="protein sequence ID" value="ACG60646.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK097542">
<property type="protein sequence ID" value="BAC05094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK297181">
<property type="protein sequence ID" value="BAG59672.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR450310">
<property type="protein sequence ID" value="CAG29306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ314866">
<property type="protein sequence ID" value="ABC40725.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC091153">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471108">
<property type="protein sequence ID" value="EAW90421.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471108">
<property type="protein sequence ID" value="EAW90422.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007427">
<property type="protein sequence ID" value="AAH07427.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067368">
<property type="protein sequence ID" value="AAH67368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11050.1">
<molecule id="P32121-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11051.1">
<molecule id="P32121-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58504.1">
<molecule id="P32121-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58505.1">
<molecule id="P32121-2"/>
</dbReference>
<dbReference type="PIR" id="S18984">
<property type="entry name" value="S18984"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244257.1">
<molecule id="P32121-4"/>
<property type="nucleotide sequence ID" value="NM_001257328.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244258.1">
<property type="nucleotide sequence ID" value="NM_001257329.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244259.1">
<molecule id="P32121-3"/>
<property type="nucleotide sequence ID" value="NM_001257330.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244260.1">
<molecule id="P32121-2"/>
<property type="nucleotide sequence ID" value="NM_001257331.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001316993.1">
<property type="nucleotide sequence ID" value="NM_001330064.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004304.1">
<molecule id="P32121-1"/>
<property type="nucleotide sequence ID" value="NM_004313.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_945355.1">
<molecule id="P32121-5"/>
<property type="nucleotide sequence ID" value="NM_199004.1"/>
</dbReference>
<dbReference type="SMR" id="P32121"/>
<dbReference type="BioGRID" id="106902">
<property type="interactions" value="393"/>
</dbReference>
<dbReference type="CORUM" id="P32121"/>
<dbReference type="DIP" id="DIP-40089N"/>
<dbReference type="IntAct" id="P32121">
<property type="interactions" value="335"/>
</dbReference>
<dbReference type="MINT" id="P32121"/>
<dbReference type="STRING" id="9606.ENSP00000403701"/>
<dbReference type="MoonDB" id="P32121">
<property type="type" value="Curated"/>
</dbReference>
<dbReference type="MoonProt" id="P32121"/>
<dbReference type="TCDB" id="8.A.136.1.2">
<property type="family name" value="the beta-arrestin (arrb) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P32121"/>
<dbReference type="PhosphoSitePlus" id="P32121"/>
<dbReference type="BioMuta" id="ARRB2"/>
<dbReference type="DMDM" id="20141230"/>
<dbReference type="EPD" id="P32121"/>
<dbReference type="jPOST" id="P32121"/>
<dbReference type="MassIVE" id="P32121"/>
<dbReference type="MaxQB" id="P32121"/>
<dbReference type="PaxDb" id="P32121"/>
<dbReference type="PeptideAtlas" id="P32121"/>
<dbReference type="PRIDE" id="P32121"/>
<dbReference type="ProteomicsDB" id="35156"/>
<dbReference type="ProteomicsDB" id="54838">
<molecule id="P32121-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54839">
<molecule id="P32121-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54840">
<molecule id="P32121-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="23372">
<property type="antibodies" value="354 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="409"/>
<dbReference type="Ensembl" id="ENST00000269260">
<molecule id="P32121-1"/>
<property type="protein sequence ID" value="ENSP00000269260"/>
<property type="gene ID" value="ENSG00000141480"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000346341">
<molecule id="P32121-2"/>
<property type="protein sequence ID" value="ENSP00000341895"/>
<property type="gene ID" value="ENSG00000141480"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381488">
<molecule id="P32121-5"/>
<property type="protein sequence ID" value="ENSP00000370898"/>
<property type="gene ID" value="ENSG00000141480"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000412477">
<molecule id="P32121-4"/>
<property type="protein sequence ID" value="ENSP00000403701"/>
<property type="gene ID" value="ENSG00000141480"/>
</dbReference>
<dbReference type="GeneID" id="409"/>
<dbReference type="KEGG" id="hsa:409"/>
<dbReference type="UCSC" id="uc002fyj.4">
<molecule id="P32121-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="409"/>
<dbReference type="DisGeNET" id="409"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141480.17"/>
<dbReference type="GeneCards" id="ARRB2"/>
<dbReference type="HGNC" id="HGNC:712">
<property type="gene designation" value="ARRB2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000141480">
<property type="expression patterns" value="Tissue enhanced (bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="107941">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P32121"/>
<dbReference type="OpenTargets" id="ENSG00000141480"/>
<dbReference type="PharmGKB" id="PA60"/>
<dbReference type="eggNOG" id="KOG3865">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182887"/>
<dbReference type="HOGENOM" id="CLU_033484_1_1_1"/>
<dbReference type="InParanoid" id="P32121"/>
<dbReference type="KO" id="K04439"/>
<dbReference type="OMA" id="APEINDP"/>
<dbReference type="OrthoDB" id="783081at2759"/>
<dbReference type="PhylomeDB" id="P32121"/>
<dbReference type="TreeFam" id="TF314260"/>
<dbReference type="PathwayCommons" id="P32121"/>
<dbReference type="Reactome" id="R-HSA-2122948">
<property type="pathway name" value="Activated NOTCH1 Transmits Signal to the Nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418555">
<property type="pathway name" value="G alpha (s) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-456926">
<property type="pathway name" value="Thrombin signalling through proteinase activated receptors (PARs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5099900">
<property type="pathway name" value="WNT5A-dependent internalization of FZD4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5635838">
<property type="pathway name" value="Activation of SMO"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9649948">
<property type="pathway name" value="Signaling downstream of RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9656223">
<property type="pathway name" value="Signaling by RAF1 mutants"/>
</dbReference>
<dbReference type="SignaLink" id="P32121"/>
<dbReference type="SIGNOR" id="P32121"/>
<dbReference type="BioGRID-ORCS" id="409">
<property type="hits" value="3 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ARRB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Arrestin_beta_2"/>
<dbReference type="GenomeRNAi" id="409"/>
<dbReference type="Pharos" id="P32121">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P32121"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P32121">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141480">
<property type="expression patterns" value="Expressed in blood and 213 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P32121">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P32121">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031691">
<property type="term" value="F:alpha-1A adrenergic receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031692">
<property type="term" value="F:alpha-1B adrenergic receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031701">
<property type="term" value="F:angiotensin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990763">
<property type="term" value="F:arrestin family protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031748">
<property type="term" value="F:D1 dopamine receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031762">
<property type="term" value="F:follicle-stimulating hormone receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001664">
<property type="term" value="F:G protein-coupled receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051019">
<property type="term" value="F:mitogen-activated protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060090">
<property type="term" value="F:molecular adaptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031859">
<property type="term" value="F:platelet activating factor receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043422">
<property type="term" value="F:protein kinase B binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031702">
<property type="term" value="F:type 1 angiotensin receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031826">
<property type="term" value="F:type 2A serotonin receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007628">
<property type="term" value="P:adult walking behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002032">
<property type="term" value="P:desensitization of G protein-coupled receptor signaling pathway by arrestin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050965">
<property type="term" value="P:detection of temperature stimulus involved in sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007212">
<property type="term" value="P:dopamine receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060079">
<property type="term" value="P:excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042699">
<property type="term" value="P:follicle-stimulating hormone signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002031">
<property type="term" value="P:G protein-coupled receptor internalization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034260">
<property type="term" value="P:negative regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032691">
<property type="term" value="P:negative regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032695">
<property type="term" value="P:negative regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045953">
<property type="term" value="P:negative regulation of natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031397">
<property type="term" value="P:negative regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090201">
<property type="term" value="P:negative regulation of release of cytochrome c from mitochondria"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034392">
<property type="term" value="P:negative regulation of smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034122">
<property type="term" value="P:negative regulation of toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051928">
<property type="term" value="P:positive regulation of calcium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000727">
<property type="term" value="P:positive regulation of cardiac muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032967">
<property type="term" value="P:positive regulation of collagen biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000573">
<property type="term" value="P:positive regulation of DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904037">
<property type="term" value="P:positive regulation of epithelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002092">
<property type="term" value="P:positive regulation of receptor internalization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032226">
<property type="term" value="P:positive regulation of synaptic transmission, dopaminergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031623">
<property type="term" value="P:receptor internalization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060765">
<property type="term" value="P:regulation of androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060071">
<property type="term" value="P:Wnt signaling pathway, planar cell polarity pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.640">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.840">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000698">
<property type="entry name" value="Arrestin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011021">
<property type="entry name" value="Arrestin-like_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014752">
<property type="entry name" value="Arrestin_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR011022">
<property type="entry name" value="Arrestin_C-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR017864">
<property type="entry name" value="Arrestin_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR014753">
<property type="entry name" value="Arrestin_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11792">
<property type="entry name" value="PTHR11792"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02752">
<property type="entry name" value="Arrestin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00339">
<property type="entry name" value="Arrestin_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00309">
<property type="entry name" value="ARRESTIN"/>
</dbReference>
<dbReference type="SMART" id="SM01017">
<property type="entry name" value="Arrestin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00295">
<property type="entry name" value="ARRESTINS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0168">Coated pit</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0734">Signal transduction inhibitor</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Beta-arrestin-2" id="PRO_0000205199">
<location>
<begin position="1"/>
<end position="409"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF6" evidence="25">
<location>
<begin position="240"/>
<end position="409"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with AP2B1">
<location>
<begin position="363"/>
<end position="409"/>
</location>
</feature>
<feature type="short sequence motif" description="[DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif">
<location>
<begin position="385"/>
<end position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="3">
<location>
<position position="48"/>
</location>
</feature>
<feature type="modified residue" description="Hydroxyproline; by PHD2" evidence="39">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Hydroxyproline; by PHD2" evidence="39">
<location>
<position position="181"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="360"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="382"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 5." id="VSP_008194" evidence="47">
<location>
<begin position="39"/>
<end position="53"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_044697" evidence="47">
<original>T</original>
<variation>TVRMPLPSEGQGAGAGTVSGVG</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_008195" evidence="47 49">
<original>S</original>
<variation>SAPTPTPPLPVPP</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CHUK; when associated with A-12; A-230 and A-231.">
<original>K</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CHUK; when associated with A-11; A-230 and A-231.">
<original>K</original>
<variation>A</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits internalization of CXCR4; no effect on interaction with CXCR4." evidence="4">
<original>V</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CHUK; when associated with A-11; A-12 and A-231.">
<original>K</original>
<variation>A</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CHUK; when associated with A-11; A-12 and A-230.">
<original>K</original>
<variation>A</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with CHUK; when associated with A-382.">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with CHUK; when associated with A-360." evidence="6">
<original>T</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation." evidence="6">
<original>T</original>
<variation>A</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG59672." ref="5" evidence="50">
<original>S</original>
<variation>P</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA77577." ref="1" evidence="50">
<original>R</original>
<variation>P</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; ABG47460." ref="3" evidence="50">
<original>H</original>
<variation>R</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAG29306." ref="6" evidence="50">
<original>L</original>
<variation>P</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG59672." ref="5" evidence="50">
<original>D</original>
<variation>G</variation>
<location>
<position position="366"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P29067"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q91YI4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10644702"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973280"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877451"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12488444"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12582207"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12949261"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12958365"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14711824"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15054093"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15125834"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15205453"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15475570"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15618519"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15635042"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671180"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15699339"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15878855"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15888437"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16144840"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16280323"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16319069"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16378096"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16492667"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16516836"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16524428"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16820410"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17540773"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18419762"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18604210"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19325136"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19363159"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19620252"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19643177"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19782076"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20048153"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21255264"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22282525"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22300987"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22457824"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23341447"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23809162"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23886940"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28827538"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="23886940"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="50" type="ECO:0000305"/>
<sequence length="409" mass="46106" checksum="DEEC507D4A7B84FF" modified="2002-03-05" version="2">MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

